ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 121 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $469,000 | -13.0% | 66,026 | +4.5% | 0.00% | -25.0% |
| Q4 2018 | $539,000 | -44.0% | 63,166 | +31.3% | 0.00% | -33.3% |
| Q3 2018 | $963,000 | -4.7% | 48,116 | +22.9% | 0.01% | -14.3% |
| Q2 2018 | $1,011,000 | +20.5% | 39,151 | +11.6% | 0.01% | 0.0% |
| Q1 2018 | $839,000 | -1.9% | 35,094 | +39.0% | 0.01% | +16.7% |
| Q4 2017 | $855,000 | +82.3% | 25,241 | +13.8% | 0.01% | +100.0% |
| Q3 2017 | $469,000 | +32.9% | 22,172 | +9.9% | 0.00% | +50.0% |
| Q2 2017 | $353,000 | +6.6% | 20,182 | +6.7% | 0.00% | 0.0% |
| Q1 2017 | $331,000 | -7.3% | 18,910 | -10.5% | 0.00% | -33.3% |
| Q4 2016 | $357,000 | -22.2% | 21,125 | -24.4% | 0.00% | -25.0% |
| Q3 2016 | $459,000 | -0.2% | 27,956 | -8.0% | 0.00% | 0.0% |
| Q2 2016 | $460,000 | +32.2% | 30,382 | +26.1% | 0.00% | 0.0% |
| Q1 2016 | $348,000 | -49.3% | 24,086 | -0.7% | 0.00% | -42.9% |
| Q4 2015 | $687,000 | -85.3% | 24,268 | -13.0% | 0.01% | +40.0% |
| Q3 2015 | $4,670,000 | +906.5% | 27,896 | +57.7% | 0.01% | +25.0% |
| Q2 2015 | $464,000 | – | 17,685 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|